Literature DB >> 2567121

A prospective analysis of 24 episodes of neuroleptic malignant syndrome.

P Rosebush1, T Stewart.   

Abstract

The authors prospectively studied 24 consecutive cases of neuroleptic malignant syndrome occurring in 20 patients in a general hospital over a 6-year period. They present detailed data concerning the clinical setting in which neuroleptic malignant syndrome occurs, the associated clinical and laboratory features, the favorable outcome that can be achieved with vigorous supportive therapy, and the factors that might help predict whether patients with neuroleptic malignant syndrome will subsequently be able to tolerate the reintroduction of neuroleptic medication.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567121     DOI: 10.1176/ajp.146.6.717

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  43 in total

1.  Recognizing neuroleptic malignant syndrome.

Authors:  Patricia I Rosebush; Sarah Garside; Michael F Mazurek
Journal:  CMAJ       Date:  2004-05-25       Impact factor: 8.262

Review 2.  Psychiatry.

Authors:  K Granville-Grossman
Journal:  Postgrad Med J       Date:  1990-09       Impact factor: 2.401

Review 3.  Neuroleptic malignant syndrome: a neuroimmunologic hypothesis.

Authors:  Rebecca E Anglin; Patricia I Rosebush; Michael F Mazurek
Journal:  CMAJ       Date:  2010-08-09       Impact factor: 8.262

4.  Risperidone-induced neuroleptic malignant syndrome in neurodegenerative disease: a case report.

Authors:  Daniel Johnson; Aby Z Philip; Dennis J Joseph; Roy Varghese
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

5.  Neuroleptic malignant syndrome without the use of neuroleptics.

Authors:  D Heyland; M Sauvé
Journal:  CMAJ       Date:  1991-10-01       Impact factor: 8.262

Review 6.  Neuroleptic malignant syndrome--follow-up study.

Authors:  P Buckley; A Freyne; A McCarthy; C Larkin
Journal:  Ir J Med Sci       Date:  1991-02       Impact factor: 1.568

7.  Serotonin syndrome: not a benign toxidrome.

Authors:  Sarah Garside; Patricia I Rosebush
Journal:  CMAJ       Date:  2003-09-16       Impact factor: 8.262

Review 8.  [Malignant hyperthermia syndrome in the intensive care unit : Differential diagnosis and acute measures].

Authors:  W Grander
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-06-07       Impact factor: 0.840

Review 9.  Catatonia and its treatment.

Authors:  Patricia I Rosebush; Michael F Mazurek
Journal:  Schizophr Bull       Date:  2009-12-07       Impact factor: 9.306

10.  Prevalence of neuroleptic malignant syndrome in 672 consecutive male in-patients.

Authors:  Pradyot Sarkar; Chandrashekhar Natarajan; Neeta Gode
Journal:  Indian J Psychiatry       Date:  2009 Jul-Sep       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.